Julia Roeper

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Petros Christopoulos, Martina Kirchner, Julia Roeper et al. · Lung Cancer · 2020 · 42 citations

Medicine, Molecular Medicine, Oncology +16

TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib

Julia Roeper, Petros Christopoulos, Markus Falk et al. · Translational Lung Cancer Research · 2022 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC

Julia Roeper, Markus Falk, Athena Chalaris-Rißmann et al. · Oncotarget · 2020 · 31 citations · Full text

Medicine, Hematology, Oncology +17

Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation

Eva‐Maria Willing, Claudia Vollbrecht, Christine Vössing et al. · Cancers · 2023 · 27 citations · Full text

Medicine, Genetics, Oncology +17

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

Petros Christopoulos, Klaus Kluck, Martina Kirchner et al. · European Journal of Cancer · 2022 · 25 citations

Medicine, Molecular Genetics, Oncology +15